Cipla Board expected to declare FY 2023–24 final dividend on May 10 Sneha Sengupta Apr 6, 2024 The medication manufacturer added that the Board will consider whether to recommend a final dividend for the fiscal year 2023–2024.
Sanofi and Cipla enters exclusive distribution agreement to widen CNS portfolio’s reach in… Sneha Sengupta Mar 26, 2024 Cipla will manage the distribution of Sanofi India's six CNS brands as part of this partnership, including the market-leading Frisium® brand of anti-epileptic medications.
